Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Open accessThe DOI matches its Crossref record; 773 of the 831 references it cites were found in a registry or an index; 177 of the 559 sources its claims cite were checked for support.
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.
Overview
CoChat Summary
TL;DR
This review summarizes current understanding of congenital adrenal hyperplasia (CAH), predominantly 21-hydroxylase deficiency (21OHD), covering steroidogenesis, genetics, diagnosis, management, and long-term outcomes. It emphasizes a phenotypic continuum, newer biomarkers and therapies, and persistent evidence gaps in treatment and surgical care.
Key findings
- 21OHD accounts for approximately 90–99% of CAH; classic CAH incidence is about 1 in 14,000 to 18,000 by newborn screening, while nonclassic (NC) CAH is estimated at ~1 in 200 in the Caucasian population.
- Genotype correlates with the less severely impaired CYP21A2 allele: 96% of individuals with two Group 0 alleles have salt-wasting CAH, whereas 97% of those with at least one Group C allele have NC CAH; residual enzyme activity is ~1–5% in simple virilizing and ~20–50% in NC CAH.
- Long-term sequelae include testicular adrenal rest tumors (TARTs) in males (reported prevalence 14–86%, average 25% in adolescents and 46% in men), adrenal masses in ~20–30% of adults, and increased mortality; adrenal crises caused 42% of deaths in a Swedish cohort, with mean age at death 54.8 years versus 72.8 years in controls.
- Newer concepts include 11-oxo-androgens such as 11-ketotestosterone as biomarkers, the backdoor pathway to dihydrotestosterone, and novel therapies (CRHR1 antagonists, abiraterone, modified-release hydrocortisone, gene/cell-based approaches), though many lack peer-reviewed long-term outcomes.
Methods
- Narrative, multi-authored review resulting from a planned European CAH Symposium postponed due to the COVID-19 pandemic; it covers pathophysiology, diagnostics, management, long-term sequelae, developing-country challenges, and future directions.
- Evidence base is a synthesis of published literature, clinical guidelines (including the 2018 Endocrine Society guideline), registries, observational studies, meta-analyses, and clinical trials; no primary patient cohort or systematic search is described.
- Main analysis is narrative synthesis, with tables and figures summarizing incidence, allele frequencies, treatment dosing, monitoring, and prenatal dexamethasone outcomes.
Limitations
- Stated: there are no large-scale prospective randomized trials for any therapies discussed; evidence is generally low or moderate quality and rests partly on expert opinion, values, and preferences.
- Stated: no evidence-based guidelines for surgical management exist, and there are no studies comparing different feminizing surgery techniques or early versus late surgery; genotype-phenotype correlations are strong but not absolute, and many neuroimaging studies are hindered by small sample size.
- Evident: as a narrative review, it does not report a systematic search strategy, formal risk-of-bias assessment, or quantitative synthesis; conclusions depend on the cited literature and expert consensus.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
86 Valid · 78 Not valid · 186 Not checked · 76 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Supraphysiological dosages of glucocorticoids similar to those used to treat classic CAH patients may be necessary to suppress adrenal androgen production (426).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Growth
What the sources say
- Disputedcites [426] Livadas, 2019, Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach, Front Endocrinol (Lausanne). sourceExperimental — accuracy not yet measured
In “NCCAH Management From the First Manifestation to the Adult Life” (page unavailable), the paper says glucocorticoids are generally given at replacement, not pharmacological, doses to decrease adrenal androgen production. Its “Management During Childhood” section adds that very high doses are needed to suppress 17-OHP and progesterone, not that supraphysiological doses are necessary to suppress adrenal androgens. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Females do outnumber males in some(12,240,241) although not all (242) retrospective studies in which CAH was clinically diagnosed without neonatal screening.”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [12] Dumic, 2009, Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006, Horm Res. source
- Not checked — no full text of the sourcecites [240] Hird, 2014, No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening, Arch Dis Child. source
- Disputedcites [241] Riedl, 2019, Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients, Endocr Connect. sourceExperimental — accuracy not yet measured
Citation (242) is attached to “not all,” offering this study as an example of a retrospectively studied, clinically diagnosed prescreening group without a female majority. The Results (Eligible patients; page unavailable) say the opposite: females made up 64% of the prescreening group. The approximately equal sex distribution was in the screened group, which does not fit that clause. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A single-dose, fixed-sequence study of 8 women given 300 or 600 mg of the CRHR1 antagonist NBI77860 at 2200 (10 PM) showed significant reductions in ACTH and 17OHP over the ensuing 16 hours relative to a control period during which glucocorticoid treatment was withheld (498).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
What the sources say
- Disputedcites [498] Sanders, 2018, Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies, Vet Res Commun. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a causen = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excessive nighttime glucocorticoid administration has potential adverse metabolic consequences (371,382).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [371] Han, 2013, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia, Clin Endocrinol (Oxf). source
- Partly supportedcites [382] Whitaker, 2014, An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure, Clin Endocrinol (Oxf). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says cortisol is normally low around midnight and that loss of its rhythm is associated with insulin resistance. It also suggests physiological replacement may help metabolic homeostasis. These passages support a potential metabolic concern, but the paper does not specifically state that excessive nighttime glucocorticoid administration has adverse metabolic consequences. (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Low expression of CYP21A2 during the second trimester partially explains the high incidence of false-positives in newborn screens for CAH in premature infants (see section IV.A)(159).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Pattern of CYP21A2 expression
What the sources say
- Could not verifycites [159] Zhou, 1997, Steroid 21-hydroxylase expression and activity in human lymphocytes, Mol Cell Endocrinol. sourceExperimental — accuracy not yet measured
Section 3.1 reports CYP21 expression in cultured lymphoid cells, including cells from CAH patients, but does not examine expression during the second trimester. Searches for premature infants, newborn screening, and false positives found no passage addressing the proposed explanation. (LLM, conf=0.76)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
207 more claims · 72 with their cited sources checked
Create a free account to see all 426 claims and to verify the 50 references still open.
- It may state two separate claims as one. 172
- Probably not a substantial claim. 64
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports in European, Mediterranean, Middle Eastern, and Chinese populations confirmed a high frequency of the pathogenic IVS2-13A/C > G and found it to comprise 20 to 25% of the CYP21A2 mutant alleles and to translate to the most severe SW forms of the disease when inherited in homozygosity [1, 4, 27, 39–43].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When combined with complementary methods such MLPA for copy number analysis, it provides nearly complete diagnostic coverage, identifying up to 98-99% of classical pathogenic alleles in most populations (1, 16, 76).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [76]
In the citing paper
“Although CAH is rare, the most common form is caused by steroid 21-hydroxylase deficiency (21-OHD) and is an autosomal-recessive disorder of adrenal steroidogenesis that results from CYP21A2 mutations.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [1]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Sodium chloride supplements 1-2 g (17-24 mEq/day) in infancy”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Graphical Abstract
Reported 24 · recomputed 34
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“A recent meta-analysis of 48 CAH cases, 34 (71%) described symptomatic improvement after bilateral adrenalectomy but with 34 cases (10%) reporting short-term and 13 cases (27%) long-term adverse outcomes”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
Reported 10 · recomputed 70.833333
Citations
Cites
Items 601–773 of 773
Mutation Analysis of the CYP21A2 Gene in the Iranian Population
Rabbani, B., Mahdieh, N., Ashtıani, M. T. H., Larijani, B. A., Akbari, M. T., New, M. I., Parsa, A. A., Schouten, J. P., & Rabbani, A. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0099 · Cited by 32
Shaw, G., Fenelon, J., Sichlau, M., Auchus, R. J., Wilson, J. D., & Renfree, M. B. (2006) · Endocrinology · doi:10.1210/en.2005-1251 · Cited by 32
Self-citationKarlsson, L., Nordenström, A., Hirvikoski, T., & Lajić, S. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.033 · Cited by 32
Self-citationEvaluation of the Dutch neonatal screening for congenital adrenal hyperplasia
van der Linde, A. A. A., Schönbeck, Y., van der Kamp, H. J., van den Akker, E. L. T., van Albada, M. E., Boelen, A., Finken, M. J. J., Hannema, S. E., Hoorweg-Nijman, G., Odink, R. J., et al. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-315972 · Cited by 32
Lai, F., Srinivasan, S., & Wiley, V. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030063 · Cited by 32
Chan, A. O. K., But, W. M., Ng, K. L., Wong, L. M., Lam, Y. Y., Tiu, S. C., Lee, K. F., Lee, C. Y., Loung, P. Y., Berry, I. R., et al. (2011) · Steroids · doi:10.1016/j.steroids.2011.04.010 · Cited by 32
Kim, B., Lee, M.-N., Park, H.-D., Kim, J. W., Chang, Y. S., Park, W. S., & Lee, S.-Y. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.6.578 · Cited by 32
Epidemiology of rare diseases detected by newborn screening in the Czech Republic
David, J., Chrastina, P., Pešková, K., Kožich, V., Friedecký, D., Adam, T., Hlídková, E., Vinohradská, H., Novotná, D., Hedelová, M., et al. (2019) · Central European Journal of Public Health · doi:10.21101/cejph.a5441 · Cited by 32
Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants
Güran, T., Tezel, B., Gürbüz, F., Eklioğlu, B. S., Hatipoğlu, N., Kara, C., Aydın, M., Şimşek, E., Çizmecioğlu, F. M., Özön, A., et al. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2018.2018.0117 · Cited by 32
Silveira, E., Elnecave, R., Dos Santos, E., Moura, V, Pinto, E., Van Der Linden Nader, I., Mendonca, B., & Bachega, T. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01274.x · Cited by 31
Gao, Y., Lu, L., Yu, B., Mao, J., Wang, X., Nie, M., & Wu, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa199 · Cited by 31
Tluczek, A., McKechnie, A. C., & Brown, R. (2011) · Research in Nursing & Health · doi:10.1002/nur.20452 · Cited by 31
Riveline, J., Baz, B., Nguewa, J. L., Vidal-Trécan, T., Ibrahim, F., Boudou, P., Vicaut, É., de la Perrière, A. B., Fetita, L.-S., Bréant, B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz145 · Cited by 31
Bird, I. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1592 · Cited by 31
Rushworth, R. L., Falhammar, H., Munns, C. F., Maguire, A. M., & Torpy, D. J. (2016) · International Journal of Endocrinology · doi:10.1155/2016/5748264 · Cited by 30
Self-citationNovel treatment strategies in congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2016) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000256 · Cited by 30
Self-citationThe Urinary Steroidome of Treated Children With Classic 21-Hydroxylase Deficiency
Kamrath, C., Wettstaedt, L., Boettcher, C., Hartmann, M. F., & Wudy, S. A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.08.006 · Cited by 30
Self-citationLossie, A. C., & Green, J. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1548793 · Cited by 30
Living with Congenital Adrenal Hyperplasia in Vietnam: A Survey of Parents
Armstrong, Henderson, C., Hoan, N. T., & Warne, G. L. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.10.1207 · Cited by 30
Development of a decision support tool in pediatric Differences/Disorders of Sex Development
Sandberg, D. E., Gardner, M., Kopec, K., Urbanski, M. A., Callens, N., Keegan, C. E., Yashar, B. M., Fechner, P. Y., Shnorhavorian, M., Vilain, E. J. N., et al. (2019) · Seminars in Pediatric Surgery · doi:10.1016/j.sempedsurg.2019.150838 · Cited by 30
Self-citationChallenges in prenatal treatment with dexamethasone
(2018) · PubMed · doi:10.17458/per.vol16.2018.mcpa.dexamethasone · Cited by 30
Nimkarn, S., New, M. I., & Lin-Su, K. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.8.883 · Cited by 29
Prenatal treatment of congenital adrenal hyperplasia-not standard of care
Witchel, S. F., & Miller, W. L. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9508-8 · Cited by 29
Self-citationVölkl, T. M. K., Öhl, L., Rauh, M., Schöfl, C., & Dörr, H. G. (2011) · Hormone Research in Paediatrics · doi:10.1159/000333696 · Cited by 29
Salt wasting in simple virilizing congenital adrenal hyperplasia
Frisch, H., Battelino, Τ., Schober, Ε., Baumgartner-Parzer, S., Nowotny, P., & Vierhapper, Η. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.9.1649 · Cited by 29
Neonatal Screening for Congenital Adrenal Hyperplasia: Experience and Results in Argentina
Gruñeiro-Papendieek, L., Chiesa, A., Mendez, V., & Prieto, L. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.1.73 · Cited by 29
Xu, C., Jia, W., Cheng, X., Ying, H., Chen, J., Xu, J., Guan, Q., Zhou, X., Zheng, D., Li, G., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.671 · Cited by 29
Transition of care from childhood to adulthood: congenital adrenal hyperplasia
Bachelot, A. (2018) · Endocrine development · doi:10.1159/000487523 · Cited by 29
The impact of culture on disclosure in differences of sex development
Weidler, E. M., & Peterson, K. E. (2019) · Seminars in Pediatric Surgery · doi:10.1016/j.sempedsurg.2019.150840 · Cited by 29
Steroid 21-hydroxylase expression and activity in human lymphocytes
Zhou, Z., Agarwal, V. R., Dixit, N., White, P., & Speiser, P. W. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)03997-4 · Cited by 28
Self-citationLee, H.-H., Lee, Y.-J., Wang, Y.-M., Chao, H.-T., Niu, D.-M., Chao, M.-C., Tsai, F.-J., Lo, F.-S., & Lin, S.-J. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.008 · Cited by 28
Why human cytochrome P450c21 is a progesterone 21-hydroxylase
Mizrachi, D., Wang, Z., Sharma, K. K., Gupta, M. K., Xu, K., Dwyer, C. R., & Auchus, R. J. (2011) · Biochemistry · doi:10.1021/bi102078e · Cited by 28
Self-citationClinical impact and cost efficacy of newborn screening for congenital adrenal hyperplasia
Fox, D. A., Ronsley, R., Khowaja, A. R., Haim, A., Vallance, H., Sinclair, G., & Amed, S. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.12.057 · Cited by 28
Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia
Kamrath, C., Hartmann, M. F., Pons-Kühnemann, J., & Wudy, S. A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154354 · Cited by 28
Self-citationBird, I. M., Mason, J. I., & Rainey, W. E. (1998) · Endocrine Research · doi:10.3109/07435809809032614 · Cited by 27
Mooij, C. F., Parajes, S., Pijnenburg-Kleizen, K. J., Arlt, W., Krone, N., & Claahsen-van der Grinten, H. L. (2015) · Hormone Research in Paediatrics · doi:10.1159/000374112 · Cited by 27
Self-citationBone mineral status in children with congenital adrenal hyperplasia
Fleischman, A., Ringelheim, J., Feldman, H. A., & Gordon, C. M. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.2.227 · Cited by 27
Barnard, L., Schiffer, L., Louw du-Toit, R., Tamblyn, J. A., Chen, S., Africander, D., Arlt, W., Foster, P. A., & Storbeck, K.-H. (2021) · Endocrinology · doi:10.1210/endocr/bqaa231 · Cited by 27
Self-citationDisorders of sex development-when and how to tell the patient.
Austin, J., Tamar‐Mattis, A., Mazur, T., Henwood, M. J., & Rossi, W. C. (2011) · PubMed · Cited by 27
Jeandron, D. D., & Sahakitrungruang, T. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336004 · Cited by 27
Crocetti, D., Arfini, E. A. G., Monro, S., & Yeadon-Lee, T. (2020) · Sociology of Health & Illness · doi:10.1111/1467-9566.13072 · Cited by 27
Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000545 · Cited by 27
Results from 28 Years of Newborn Screening for Congenital Adrenal Hyperplasia in Sapporo
Morikawa, S., Nakamura, A., Fujikura, K., Fukushi, M., Hotsubo, T., Miyata, J., Ishizu, K., & Tajima, T. (2014) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.23.35 · Cited by 26
Ten-year evaluation of a Neonatal Screening Program for Congenital Adrenal Hyperplasia
Nascimento, M. L., Cristiano, A. N. B., Campos, T. D., Ohira, M., Cechinel, E., Simoni, G., Lee, J. V. D. S., Linhares, R. M. M., & Silva, P. C. A. D. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003310 · Cited by 26
A three-year follow-up of congenital adrenal hyperplasia newborn screening
Pezzuti, I. L., Barra, C. B., Mantovani, R. M., Januário, J. N., & Silva, I. N. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2013.09.007 · Cited by 26
Mendes-dos-Santos, C. T., Martins, D. L., Guerra-Júnior, G., Baptista, M. T. M., de-Mello, M. P., de Oliveira, L. C., Morcillo, A. M., & Lemos-Marini, S. H. V. (2018) · Hormone Research in Paediatrics · doi:10.1159/000492082 · Cited by 26
Refining the ethics of preimplantation genetic diagnosis: a plea for contextualized proportionality
Dondorp, W., & de Wert, G. (2019) · Bioethics · doi:10.1111/bioe.12534 · Cited by 26
Grecsó, N., Zádori, A., Szécsi, I., Baráth, Á., Galla, Z., Bereczki, C., & Monostori, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233724 · Cited by 26
(2014) · Europe PMC (PubMed Central) · doi:10.2450/2014.0026-14s · Cited by 26
Porter, J., Withe, M., & Ross, R. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1455496 · Cited by 26
Individualized care for patients with intersex (disorders/differences of sex development): part I
Lee, P. A., Fuqua, J. S., Houk, C. P., Kogan, B. A., Mazur, T., & Caldamone, A. (2020) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2020.02.013 · Cited by 26
Congenital adrenal hyperplasia: transitional care
Hughes, I. A. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.015 · Cited by 25
Hird, B. E., Tetlow, L., Tobi, S., Patel, L., & Clayton, P. E. (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304473 · Cited by 25
Bonfig, W., Roehl, F., Riedl, S., Brämswig, J., Richter-Unruh, A., Fricke-Otto, S., Hübner, A., Bettendorf, M., Schönau, E., Dörr, H., et al. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481775 · Cited by 25
Barnard, L., Nikolaou, N., Louw, C., Schiffer, L., Gibson, H., Gilligan, L. C., Gangitano, E., Snoep, J., Arlt, W., Tomlinson, J. W., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105724 · Cited by 25
Self-citationGonzalez, R. R., Mäentausta, O., Solyom, J., & Vihko, R. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.9.1667 · Cited by 25
Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia
King, J. L., Naber, J. M., Hopkin, R. J., Repaske, D. R., Bailey, L., & Leslie, N. D. (2001) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.155.9.1038 · Cited by 24
Mnif, M. F., Kamoun, M., Mnif, F., Charfi, N., Kallel, N., Rekik, N., Naceur, B. B., Fourati, H., Daoud, E., Mnif, Z., et al. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.107833 · Cited by 24
Kocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Self-citationErnst, M. M., Kogan, B. A., & Lee, P. A. (2020) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2020.06.026 · Cited by 24
Quinlivan, J. A., Dunlop, S., Newnham, J. P., Evans, S. F., & Beazley, L. (1999) · UWA Profiles and Research Repository (UWA) · Cited by 24
An Examination of Parenting Variables and Child Self-Care Behavior Across Disease Groups
Bourdeau, T., Mullins, L. L., Carpentier, M. Y., Colletti, C. J. M., & Wolfe-Christensen, C. B. (2007) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-007-9037-9 · Cited by 23
Kulshreshtha, B., Marumudi, E., Khurana, M. L., Kriplani, A., Kinra, G., Gupta, D. K., Kucheria, K., Khadgawat, R., Gupta, N., Seith, A., et al. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801945230 · Cited by 23
Forest, M. G., & Dörr, H. G. (1993) · Pediatric Research · doi:10.1203/00006450-199305001-00011 · Cited by 23
Determinant factors of gender identity: a commentary
Liao, L.-M., Audi, L., Magritte, E., Meyer-Bahlburg, H. F. L., & Quigley, C. A. (2012) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2012.09.009 · Cited by 23
Apparent mineralocorticoid excess syndrome: report of one family with three affected children
Al-Harbi, T., & Shaikh, A. M. A. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0113 · Cited by 23
Lampalzer, U., Briken, P., & Schweizer, K. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.03.002 · Cited by 23
on behalf of the German Society of Pediatric Endocrinology and Diabetology, Dörr, H. G., Wollmann, H. A., Hauffa, B. P., & Woelfle, J. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0263-1 · Cited by 22
de Silva, K. S. H., de Zoysa, P., Dilanka, W. M. S., & Dissanayake, B. S. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0267 · Cited by 22
Pijnenburg-Kleizen, K. J., Borm, G. F., Otten, B. J., Schott, D. A., van den Akker, E. L., Stokvis-Brantsma, W. H., Voorhoeve, P. G., Bakker, B., & Claahsen-van der Grinten, H. L. (2012) · Hormone Research in Paediatrics · doi:10.1159/000337217 · Cited by 22
Characterizing the steroidal milieu in amniotic fluid of mid-gestation: a GC-MS study
Wang, R., Hartmann, M. F., Tiosano, D., & Wudy, S. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105412 · Cited by 22
Vijayan, R., Bhavani, N., Pavithran, P. V., Nair, V., Menon, U. V., Menon, A. S., Abraham, N., Bhadran, K., Narayanan, P., & Kumar, H. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0079 · Cited by 22
Newborn screening for congenital adrenal hyperplasia in Cuba: Six years of experience
Reyes, E. C. G., Carvajal, F., Frómeta, A., Arteaga, A. L., Martínez, E. M. C., Espinosa, T., Coto, R., Pérez, P. L., Tejeda, Y., del Río, L., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.020 · Cited by 21
Jang, J., Jin, D., Kim, J., Tan, H.-K., Kim, J.-W., Lee, S., Ki, C., & Park, H. (2011) · PubMed · Cited by 21
Odenwald, B., Dörr, H. G., Bonfig, W., Schmidt, H., Fingerhut, R., Wildner, M., & Nennstiel, U. (2015) · Klinische Pädiatrie · doi:10.1055/s-0035-1554639 · Cited by 21
Gehrand, A. L., Phillips, J., Malott, K., & Raff, H. (2019) · Endocrinology · doi:10.1210/en.2019-00117 · Cited by 21
Stein, R. E. K. (2011) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2011.165 · Cited by 21
Nguyen, H.-H., Eiden-Plach, A., Hannemann, F., Malunowicz, E. M., Hartmann, M. F., Wudy, S. A., & Bernhardt, R. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.011 · Cited by 21
Self-citationSanders, C., Hall, J., Sanders, C., Dessens, A., Bryce, J., Callens, N., Cools, M., Kourime, M., Kyriakou, A., Springer, A., et al. (2018) · Sexual Development · doi:10.1159/000490081 · Cited by 21
Self-citationJiang, X., Tang, F., Feng, Y., Li, B., Jia, X., Tang, C., Liu, S., & Huang, Y. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0140 · Cited by 21
Németh, S., Riedl, S., Kriegshäuser, G., Baumgartner-Parzer, S., Concolino, P., Neocleous, V., Phylactou, L. A., Borucka-Mankiewicz, M., Onay, H., Tukun, A., et al. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.09.013 · Cited by 20
Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening
De Jesús, V. R., Simms, D. A., Schiffer, J., Kennedy, M., Mei, J. V., & Hannon, W. H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.06.029 · Cited by 20
Charmandari, E., Chrousos, G. P., & Merke, D. P. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.1.97 · Cited by 20
Self-citationChin, K. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.8.1959 · Cited by 20
Tanaka, M., Enatsu, N., Chiba, K., & Fujisawa, M. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12068 · Cited by 20
Lolis, E., Juhlin, C. C., Nordenström, A., & Falhammar, H. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00082 · Cited by 20
Self-citationPallan, P. S., Lei, L., Wang, C., Waterman, M. R., Guengerich, F. P., & Egli, M. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1127 · Cited by 19
Tieh, P. Y., Yee, J. K., Hicks, R. A., Mao, C. S., & Lee, W.-N. (2017) · Journal of Perinatology · doi:10.1038/jp.2016.223 · Cited by 19
Wallensteen, L., Karlsson, L., Messina, V., Gezelius, A., Sandberg, M. T., Nordenström, A., Hirvikoski, T., & Lajić, S. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.11.004 · Cited by 19
Self-citationBurman, P., Falhammar, H., Waldenström, E., Sundin, A., & Bitzèn, U. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa870 · Cited by 19
Self-citationVitkin, E. I., Ben‐Dor, A., Shmoish, M., Hartmann, M. F., Yakhini, Z., Wudy, S. A., & Hochberg, Z. (2014) · Steroids · doi:10.1016/j.steroids.2014.07.003 · Cited by 19
Self-citationBen Charfeddine, I., Riepe, F. G., Clauser, E., Ayedi, A., Makni, S., Sfar, M. T., Sboui, H., Kahloul, N., Ben Hamouda, H., Chouchane, S., et al. (2012) · Gene · doi:10.1016/j.gene.2012.07.027 · Cited by 19
Ammini, A., Kulshreshtha, B., & Eunice, M. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.98018 · Cited by 19
Johnson, E. K., Rosoklija, I., Finlayson, C. A., Chen, D., Yerkes, E. B., Madonna, M. B., Holl, J. L., Baratz, A. B., Davis, G., & Cheng, E. Y. (2017) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2017.04.007 · Cited by 19
Application of principal component analysis to newborn screening for congenital adrenal hyperplasia
Lasarev, M. R., Bialk, E. R., Allen, D. B., & Held, P. K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa371 · Cited by 19
Nordenström, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1210 · Cited by 19
Self-citationChen, W., Xu, Z., Nishitani, M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2012) · Human Genetics · doi:10.1007/s00439-012-1217-8 · Cited by 18
Self-citationde Groot, M. J. M., Pijnenburg-Kleizen, K. J., Thomas, C. M. G., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., Otten, B. J., & Claahsen-van der Grinten, H. L. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0375 · Cited by 18
Liu, S.-Y., Lee, C.-T., Tung, Y.-C., Chien, Y.-H., Hwu, W.-L., & Tsai, W.-Y. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.03.008 · Cited by 18
How the child’s gender matters for families having a child with congenital adrenal hyperplasia
Fleming, L., Knafl, K., & Van Riper, M. (2017) · Journal of Family Nursing · doi:10.1177/1074840717735499 · Cited by 18
Kamrath, C., Wettstaedt, L., Hartmann, M. F., & Wudy, S. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00438 · Cited by 18
Self-citationWallensteen, L., Karlsson, L., Messina, V., Nordenström, A., & Lajić, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa280 · Cited by 18
Self-citationShetty, V. B., Bower, C., Jones, T. W., Lewis, B. D., & Davis, E. A. (2012) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2012.02584.x · Cited by 17
Stress doses of glucocorticoids cannot prevent progression of all adrenal crises
Aso, K., Izawa, M., Higuchi, A., Kotoh, S., & Hasegawa, Y. (2009) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.18.23 · Cited by 17
Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype
Gurgov, S., Bernabé, K. J., Stites, J., Cunniff, C. M., Lin‐Su, K., Felsen, D., New, M. I., & Poppas, D. P. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13370 · Cited by 17
Langhammer, M., Michaelis, M., Hartmann, M. F., Wudy, S. A., Sobczak, A., Nürnberg, G., Reinsch, N., Schön, J., & Weitzel, J. M. (2017) · Reproduction · doi:10.1530/rep-16-0434 · Cited by 17
Salem, J.-E., Nguyen, L. S., Hammoudi, N., Preud'homme, G., Hulot, J.-S., Leban, M., Funck-Brentano, C., Touraine, P., Isnard, R., Bachelot, A., et al. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.10.017 · Cited by 17
Self-citation(2017) · PubMed · doi:10.17458/per.vol15.2017.rvc.prenataltreatment · Cited by 16
Self-citationHeland, S., Hewitt, J. K., McGillivray, G., & Walker, S. P. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12423 · Cited by 16
Han, L., Tavakoli, N. P., Morrissey, M., Spink, D. C., & Cao, Z. (. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1449-0 · Cited by 16
Individualized care for patients with intersex (disorders/differences of sex development): Part 3
Krishna, K. B., Kogan, B. A., Ernst, M. M., Romao, R. L. P., Mohsin, F., Gonzalez, M. S., Quintos, J. B., Phornphutkul, C., Aguiar, L. M., & Lee, P. A. (2020) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2020.06.004 · Cited by 16
Ubertini, G., Bizzarri, C., Grossi, A., Gimigliano, F., Ravà, L., Fintini, D., & Cappa, M. (2009) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2009-383610 · Cited by 16
Flück, C. E., Parween, S., Rojas Velazquez, M. N., & Pandey, A. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003154117 · Cited by 15
Self-citationEarly central blood pressure elevation in adult patients with 21-hydroxylase deficiency
Rosenbaum, D., Gallo, A., Lethielleux, G., Bruckert, E., Levy, B. I., Tanguy, M. L., Dulon, J., Dahmoune, N., Salem, J. E., Bittar, R., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000001850 · Cited by 15
Self-citationIdentity, sexuality, and parenthood in women with congenital adrenal hyperplasia
Engberg, H., Möller, A., Hagenfeldt, K., Nordenskjöld, A., & Frisén, L. (2020) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2020.05.005 · Cited by 15
Nonclassical congenital adrenal hyperplasia: targets of treatment and transition.
McCann‐Crosby, B., Chen, M.-J., Lyons, S. K., Lin, Y., Axelrad, M. E., Dietrich, J. E., Sutton, V. R., Macias, C. G., Gunn, S., & Karaviti, L. P. (2014) · PubMed · Cited by 14
Ethics, genetics and public policies in Uruguay: newborn and infant screening as a paradigm
Larrandaburu, M., Matte, Ú. D. S., Noble, A., et al. (2015) · Journal of Community Genetics · doi:10.1007/s12687-015-0236-2 · Cited by 14
Therapy monitoring in congenital adrenal hyperplasia by dried blood samples
Wieacker, I., Peter, M., Borucki, K., Empting, S., Roehl, F.-W., & Mohnike, K. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0303 · Cited by 14
Breast development and satisfaction in women with disorders/differences of sex development
van de Grift, T. C., Kreukels, B. P. C., & dsd-LIFE (2019) · Human Reproduction · doi:10.1093/humrep/dez230 · Cited by 14
Dörr, H.-G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-020-00100-w · Cited by 14
Kim, J. H., Choi, J., Kang, E., Kim, Y.-M., Lee, B., & Yoo, H. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-123037 · Cited by 14
Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid
Peng, H.-M., Barlow, C., & Auchus, R. J. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.03.003 · Cited by 14
Interventions for female pattern hair loss
(2012) · Prescriber · doi:10.1002/psb.925 · Cited by 14
Endoh, A. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00224-4 · Cited by 13
Lange-Kubini, K., ZACHMANN, M., Kempken, B., & Torresani, T. (1996) · European Journal of Pediatrics · doi:10.1007/bf02282880 · Cited by 13
Grunt, S., Steinlin, M., Weisstanner, C., Schöning, M., Mullis, P. E., & Flück, C. E. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348515 · Cited by 13
Self-citationManojlović-Stojanoski, M. N., Filipović, B. R., Nestorović, N. M., Šošić-Jurjević, B. T., Ristić, N. M., Trifunović, S. L., & Milošević, V. L. (2014) · Steroids · doi:10.1016/j.steroids.2014.03.006 · Cited by 13
The Medical Home Concept and Congenital Adrenal Hyperplasia: A Comfortable Habitat!
Witchel, S. F. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/561526 · Cited by 13
Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies
Sanders, K., Mol, J. A., Kooistra, H. S., & Galac, S. (2018) · Veterinary Research Communications · doi:10.1007/s11259-018-9737-x · Cited by 13
Costello, E. J., & Angold, A. (2016) · Developmental Psychopathology · doi:10.1002/9781119125556.devpsy103 · Cited by 13
Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Murata, M., & Hasegawa, T. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.37 · Cited by 13
Kyllo, J. H., Collins, M. M., & Donohoue, P. A. (1995) · Endocrine Research · doi:10.1080/07435809509030491 · Cited by 12
Greaves, R. F., Jolly, L., Hartmann, M. F., Ho, C. S., Kam, R. K. T., Joseph, J., Boyder, C., & Wudy, S. A. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0394 · Cited by 12
Self-citationLao, Q., Jardin, M. D., Jayakrishnan, R., Ernst, M., & Merke, D. P. (2018) · Human Genetics · doi:10.1007/s00439-018-1959-z · Cited by 12
Self-citationDumic, K., Krnic, N., Skrabic, V., Stipancic, G., Cvijovic, K., Kusec, V., & Stingl, K. (2009) · Hormone Research in Paediatrics · doi:10.1159/000245933 · Cited by 12
Xu, L., Lin, W., Cai, L., Huang, H., Liang, J., Li, L., Zong, L., Wang, N., Wen, J., & Chen, G. (2020) · Clinical Endocrinology · doi:10.1111/cen.14126 · Cited by 12
The virilized female: endocrine background
Forest, M. G., Nicolino, M., David, M., & Morel, Y. (2004) · BJU International · doi:10.1111/j.1464-410x.2004.04707.x · Cited by 12
Schoer, M. B., Nguyen, P. N., Merritt, D. F., Wesevich, V. G., & Hollander, A. (2018) · Clinical Pediatrics · doi:10.1177/0009922818803407 · Cited by 12
Ediati, A., Verrips, G. H. W., Juniarto, A. Z., Faradz, S. M. H., Drop, S. L. S., & Dessens, A. B. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00434 · Cited by 12
Dumic, K., Krnic, N., Skrabic, V., Stipancic, G., Cvijovic, K., Kusec, V., & Stingl, K. (2009) · Hormone Research in Paediatrics · doi:10.1159/000236086 · Cited by 11
A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing
Gong, L.-F., Gao, X., Yang, N., Zhao, J.-Q., Yang, H.-H., & Kong, Y.-Y. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0342 · Cited by 11
The Medical Home Concept and Congenital Adrenal Hyperplasia: a Comfortable Habitat!
Witchel, S. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-561526 · Cited by 11
Wilson, J. D., Shaw, G., Renfree, M. B., Auchus, R. J., Leihy, M. W., & Eckery, D. C. (2005) · Reproduction Fertility and Development · doi:10.1071/rd05034 · Cited by 10
Self-citationHeberden, C., Meffray, E., Goustard-Langelier, B., Maximin, E., & Lavialle, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.07.010 · Cited by 10
Fanis, P., Neocleous, V., Kosta, K., Karipiadou, A., Hartmann, M. F., Wudy, S. A., Karantaglis, N., Papadimitriou, D. T., Skordis, N., Tsikopoulos, G., et al. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0245 · Cited by 10
Self-citationMedical treatment of classic and nonclassic congenital adrenal hyperplasia
Speiser, P. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_9 · Cited by 10
Self-citationAnalysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China
Hou, L., Liang, L., Lin, S., Ou, H., Liu, Z., Huang, S., Zhang, L., & Meng, Z. (2019) · Steroids · doi:10.1016/j.steroids.2019.108474 · Cited by 10
Neuropsychological functioning in patients with Cushing’s disease and Cushing’s syndrome
Siegel, S., Kirstein, C. F., Grzywotz, A., Hütter, B. O., Wrede, K. H., Kuhna, V., & Kreitschmann-Andermahr, I. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1247-4651 · Cited by 10
Chowdhury, T. K., Kabir, M., Chowdhury, M. Z., Hutson, J. M., & Banu, T. (2014) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2014.06.021 · Cited by 9
Lottspeich, C., Müller-Lisse, U., Seiler, L., Schmitt-Graeff, A. H., Reincke, M., & Reisch, N. (2019) · Urology · doi:10.1016/j.urology.2019.03.005 · Cited by 9
Self-citationMalaysian Females With Congenital Adrenal Hyperplasia: Surgical Outcomes and Attitudes
Zainuddin, A. A., Grover, S. R., Soon, C. H., Azurah, A. G. N., Mahdy, Z. A., Wu, L. L., Rasat, R., Harun, F., Chia, W. Y., & Shamsuddin, K. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00144 · Cited by 9
Peng, Y., Shinde, D. N., Valencia, C. A., Mo, J.-S., Rosenfeld, J. A., Cho, M. T., Chamberlin, A. C., Li, Z., Liu, J., & Gui, B. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy072 · Cited by 9
Ziejewski, M. K., Solomon, H. M., Stanislaus, D., Clark, R. L., White, T. E., & Apostoli, A. R. (2012) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20341 · Cited by 8
Wilson, J. D., Renfree, M. B., Auchus, R. J., Pask, A. J., & Shaw, G. (2009) · Reproduction Fertility and Development · doi:10.1071/rd08253 · Cited by 8
Self-citationAchieving diagnostic certainty in resource-limited settings
Mazen, I., & Raza, J. (2014) · Endocrine Development · doi:10.1159/000363672 · Cited by 8
Risk factors for hospitalization of children with congenital adrenal hyperplasia
Yang, M., & White, P. C. (2017) · Clinical Endocrinology · doi:10.1111/cen.13309 · Cited by 7
Self-citationChrisp, G. L., Torpy, D. J., Maguire, A. M., Quartararo, M., Falhammar, H., King, B. R., Munns, C. F., Hameed, S., & Rushworth, R. L. (2020) · Clinical Endocrinology · doi:10.1111/cen.14196 · Cited by 7
Self-citationAltieri, V. M., Altieri, B., Castellucci, R., Alba, S., Bottone, F., Fragalà, E., Mirone, V., & Greco, F. (2016) · Urologia Journal · doi:10.5301/uro.5000162 · Cited by 6
Re: Testicular Adrenal Rest Tumors in Boys and Young Adults with Congenital Adrenal Hyperplasia
Verhees, M. J. M., Ulzen, K. K.-V., Hermus, A. R. M. M., Stikkelbroeck, N. M. M. L., Mooij, C. F., & der Grinten, H. L. C. (2018) · The Journal of Urology · doi:10.1016/j.juro.2017.11.122 · Cited by 6
Self-citation(2020) · PubMed · Cited by 6
(2017) · PubMed · Cited by 6
Zainuddin, A. A., Grover, S. R., Soon, C. H., Ghani, N. A. A., Mahdy, Z. A., Manaf, M. R. A., & Shamsuddin, K. (2020) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2020.04.008 · Cited by 6
Reisch, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., & Arlt, W. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007695117 · Cited by 6
Self-citationPhenotypic variation of 46,XX late identified congenital adrenal hyperplasia among Indonesians
Center for Biomedical Research (CEBIOR), F. O. M. D. U., Juniarto, A. Z., Ulfah, M., Ariani, M. D., Utari, A., & Faradz, S. M. (2018) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.033.01.02 · Cited by 5
Self-citationMerke, D. P., Mallappa, A., Arlt, W., de la Perriere, A. B., Hirschberg, A. L., Juul, A., Newell-Price, J. D. C., Perry, C. G., Prete, A., Rees, A., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa046.214 · Cited by 4
Self-citationA steroid metabolomic approach to 17α-hydroxylase/17,20 lyase deficiency
Tiosano, D., Navon, R., Flor, O., Knopf, C., Hartmann, M. F., Wudy, S. A., Yakhini, Z., & Hochberg, Z. (2010) · Metabolomics · doi:10.1007/s11306-010-0217-8 · Cited by 4
Self-citationA delayed diagnosis of salt-wasting congenital adrenal hyperplasia
Pijnenburg‐Kleizen, K. J., Noordam, C., Otten, B. J., & Claahsen‐van der Grinten, H. L. (2016) · Clinical Endocrinology · doi:10.1111/cen.13108 · Cited by 4
Simpson, J. L. (1993) · JAMA · doi:10.1001/jama.1993.03510190113036 · Cited by 4
A three-year follow-up of congenital adrenal hyperplasia newborn screening
Pezzuti, I. L., Barra, C. B., Mantovani, R. M., Januário, J. N., & Silva, I. N. (2014) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2013.08.006 · Cited by 3
Lange-Kubini, K., Zachmann, M., Kempken, B., & Torresani, T. (1997) · Early Human Development · doi:10.1016/s0378-3782(97)90554-5 · Cited by 1
A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing
Gong, L., Gao, X., Yang, N., Zhao, J., He, Y., & Kong, Y. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.13.7 · Cited by 1
Völkl, T. M. K., Öhl, L., Rauh, M., Schöfl, C., & Dörr, H. G. (2011) · Figshare · doi:10.6084/m9.figshare.5122978
Alternative pathway androgen biosynthesis and human fetal female virilization
Reisch, N., Taylor, A. E., Nogueira, E. F., Asby, D. J., Dhir, V., Berry, A., Krone, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., et al. (2019) · doi:10.1101/609289
Self-citation
Research works printed but not linked: 2
- McCann-Crosby, 2014, Non classic CAH; targets of treatment and transition, Pediatr Endocr Rev., 12, 224
- Auchus, 2012, Abiraterone acetate added to physiologic hydrocortisone dosing safely controls androgen excess in adult women with classical 21-hydroxylase deficiency, Endocr Rev., 33, SUN-LB2
Cited by
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Self-citationGlucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 77
“In the most severe Salt-Wasting (SW-CAH) form, there is little or no residual enzyme activity, whereas patients with the Simple-Virilizing (SV-CAH) form still retain 1–5% enzyme activity [153].”
BackgroundPhase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Auchus, R. J., Hamidi, O., Pivonello, R., Bancos, I., Russo, G., Witchel, S. F., Isidori, A. M., Rodien, P., Srirangalingam, U., Kiefer, F. W., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2404656 · Cited by 79
Self-citation
Metadata
- Authors
- Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., Krone, N., Merke, D. P., Miller, W. L., Nordenström, A., Reisch, N., Sandberg, D. E., Stikkelbroeck, N. M. M. L., Touraine, P., Utari, A., Wudy, S. A., & White, P. C.
- Affiliations
- Department of Pediatric Endocrinology, Radboud University Medical Centre, Amalia Childrens Hospital, Nijmegen, The Netherlands
- Northwell Health (US)
- University of Glasgow (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Michigan (US)
- Karolinska University Hospital (SE)
- University of Bern (CH)
- Queen Mary University of London (GB)
- Technische Universität Dresden (DE)
- Radboud University Medical Center (NL)
- University Hospital Carl Gustav Carus (DE)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- University of California, San Francisco (US)
- LMU Klinikum (DE)
- Sorbonne Université (FR)
- Diponegoro University (ID)
- Justus-Liebig-Universität Gießen (DE)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- White, Perrin C
- ORCID
- Claahsen - van der Grinten, Hedi L
- Speiser, Phyllis W
- Ahmed, S Faisal
- Arlt, Wiebke
- Auchus, Richard J
- Falhammar, Henrik
- Flück, Christa E
- Guasti, Leonardo
- Huebner, Angela
- Krone, Nils
- Merke, Deborah P
- Miller, Walter L
- Nordenström, Anna
- Reisch, Nicole
- Sandberg, David E
- Touraine, Philippe
- Utari, Agustini
- Wudy, Stefan A
- White, Perrin C
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2021-05-07
- Volume
- 43
- Issue
- 1
- Pages
- 91-159
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W4229036110
- Semantic Scholar
- 1867a4639fab9f23f14102ccc6107c07963e64dc
- Cited by
- 556
- References
- 831
- Citations by year
- 2026: 102 · 2025: 125 · 2024: 149 · 2023: 97 · 2022: 68 · 2021: 14
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (U01-HD083493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 mutations, cortisol production, steroidogenic pathway, newborn screening, steroid profiling, genotyping, cell therapy, gene therapy, long-term outcomes, disease registries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.